CA Stock MarketDetailed Quotes

HEAL Restart Life Sciences Corp

Watchlist
  • 0.030
  • -0.005-14.29%
15min DelayTrading Dec 2 10:48 ET
1.08MMarket Cap-300P/E (TTM)

Restart Life Sciences Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
89.88%-9.76K
73.05%-46.27K
104.06%7K
80.52%-96.5K
69.98%-171.68K
25.82%-1.44M
62.77%-203.83K
54.67%-172.41K
-27.42%-495.45K
9.15%-571.93K
Net income from continuing operations
70.09%-90.58K
72.66%-144.38K
54.32%-184.06K
17.45%-302.79K
15.78%-528.01K
8.15%-2.47M
-338.91%-1.07M
71.28%-402.94K
12.87%-366.79K
-1.63%-626.93K
Depreciation and amortization
-21.50%577
-21.36%578
-22.36%736
-22.47%735
-22.47%735
-24.13%3.79K
-24.16%948
-24.10%948
-53.60%948
107.89%948
Asset impairment expenditure
----
----
----
----
----
13,963.55%764.78K
----
----
----
----
Remuneration paid in stock
--0
--0
--0
--0
62.78%273.38K
-5.74%328.45K
-84.36%2.63K
-55.51%138.2K
583.71%19.68K
827.04%167.94K
Other non cashItems
----
----
--0
--0
327.38%80K
68.00%-72.32K
123.95%53.04K
---52.68K
-835.06%-37.5K
-6,297.09%-35.18K
Change In working capital
-60.97%80.24K
4,301.35%97.53K
32.11%190.33K
283.87%205.56K
102.82%2.22K
-100.39%-2.43K
109.97%44K
-76.32%144.06K
-458.15%-111.8K
-156.59%-78.7K
-Change in receivables
929.93%3.41K
63.62%-501
-97.03%2.41K
-111.97%-411
94.83%-1.38K
218.07%62.46K
121.58%4.31K
696.26%81.35K
138.05%3.44K
-160.27%-26.64K
-Change in prepaid assets
--0
105.47%4.62K
461.38%11.44K
709.51%70.97K
-558.51%-84.42K
-91.92%30.64K
-86.78%1.42K
-99.22%2.04K
876,800.00%8.77K
-82.93%18.41K
-Change in payables and accrued expense
-43.09%76.83K
6.14%93.42K
190.85%176.47K
208.87%135K
224.89%88.01K
-131.45%-95.53K
26.72%38.27K
-83.22%60.68K
-408.11%-124K
45.08%-70.48K
Cash from discontinued investing activities
Operating cash flow
89.88%-9.76K
73.05%-46.27K
104.06%7K
80.52%-96.5K
69.98%-171.68K
25.82%-1.44M
62.77%-203.83K
54.67%-172.41K
-27.42%-495.45K
9.15%-571.93K
Investing cash flow
Cash flow from continuing investing activities
0
Net investment purchase and sale
----
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
--0
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
0
214.14%60K
0
0
-98.71%19.1K
1.49M
8.4K
0
0
1.48M
Net issuance payments of debt
--0
--60K
----
--0
--0
----
----
----
----
----
Net common stock issuance
----
----
----
----
----
--1.48M
--0
--0
--0
--1.48M
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--19.1K
--8.4K
--8.4K
----
----
--0
Cash from discontinued financing activities
Financing cash flow
--0
214.14%60K
--0
--0
-98.71%19.1K
--1.49M
--8.4K
--0
--0
--1.48M
Net cash flow
Beginning cash position
-80.85%21.82K
-96.97%8.09K
-97.25%17.44K
-89.92%113.94K
21.85%266.52K
-89.76%218.73K
-39.79%461.95K
-43.44%634.36K
-24.97%1.13M
-89.76%218.73K
Current changes in cash
89.88%-9.76K
109.00%13.73K
104.06%7K
80.52%-96.5K
-116.75%-152.58K
102.49%47.79K
64.37%-195.43K
51.34%-172.41K
-28.93%-495.45K
244.72%911.07K
End cash Position
-30.86%12.06K
-80.85%21.82K
-94.71%24.44K
-97.25%17.44K
-89.92%113.94K
21.85%266.52K
21.85%266.52K
-39.79%461.95K
-43.44%634.36K
-24.97%1.13M
Free cash from
89.88%-9.76K
73.05%-46.27K
104.06%7K
80.52%-96.5K
69.98%-171.68K
25.82%-1.44M
62.77%-203.83K
54.67%-172.41K
-27.42%-495.45K
9.15%-571.93K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 89.88%-9.76K73.05%-46.27K104.06%7K80.52%-96.5K69.98%-171.68K25.82%-1.44M62.77%-203.83K54.67%-172.41K-27.42%-495.45K9.15%-571.93K
Net income from continuing operations 70.09%-90.58K72.66%-144.38K54.32%-184.06K17.45%-302.79K15.78%-528.01K8.15%-2.47M-338.91%-1.07M71.28%-402.94K12.87%-366.79K-1.63%-626.93K
Depreciation and amortization -21.50%577-21.36%578-22.36%736-22.47%735-22.47%735-24.13%3.79K-24.16%948-24.10%948-53.60%948107.89%948
Asset impairment expenditure --------------------13,963.55%764.78K----------------
Remuneration paid in stock --0--0--0--062.78%273.38K-5.74%328.45K-84.36%2.63K-55.51%138.2K583.71%19.68K827.04%167.94K
Other non cashItems ----------0--0327.38%80K68.00%-72.32K123.95%53.04K---52.68K-835.06%-37.5K-6,297.09%-35.18K
Change In working capital -60.97%80.24K4,301.35%97.53K32.11%190.33K283.87%205.56K102.82%2.22K-100.39%-2.43K109.97%44K-76.32%144.06K-458.15%-111.8K-156.59%-78.7K
-Change in receivables 929.93%3.41K63.62%-501-97.03%2.41K-111.97%-41194.83%-1.38K218.07%62.46K121.58%4.31K696.26%81.35K138.05%3.44K-160.27%-26.64K
-Change in prepaid assets --0105.47%4.62K461.38%11.44K709.51%70.97K-558.51%-84.42K-91.92%30.64K-86.78%1.42K-99.22%2.04K876,800.00%8.77K-82.93%18.41K
-Change in payables and accrued expense -43.09%76.83K6.14%93.42K190.85%176.47K208.87%135K224.89%88.01K-131.45%-95.53K26.72%38.27K-83.22%60.68K-408.11%-124K45.08%-70.48K
Cash from discontinued investing activities
Operating cash flow 89.88%-9.76K73.05%-46.27K104.06%7K80.52%-96.5K69.98%-171.68K25.82%-1.44M62.77%-203.83K54.67%-172.41K-27.42%-495.45K9.15%-571.93K
Investing cash flow
Cash flow from continuing investing activities 0
Net investment purchase and sale ----------------------0----------------
Cash from discontinued investing activities
Investing cash flow ----------------------0----------------
Financing cash flow
Cash flow from continuing financing activities 0214.14%60K00-98.71%19.1K1.49M8.4K001.48M
Net issuance payments of debt --0--60K------0--0--------------------
Net common stock issuance ----------------------1.48M--0--0--0--1.48M
Proceeds from stock option exercised by employees --0--0--0--0--19.1K--8.4K--8.4K----------0
Cash from discontinued financing activities
Financing cash flow --0214.14%60K--0--0-98.71%19.1K--1.49M--8.4K--0--0--1.48M
Net cash flow
Beginning cash position -80.85%21.82K-96.97%8.09K-97.25%17.44K-89.92%113.94K21.85%266.52K-89.76%218.73K-39.79%461.95K-43.44%634.36K-24.97%1.13M-89.76%218.73K
Current changes in cash 89.88%-9.76K109.00%13.73K104.06%7K80.52%-96.5K-116.75%-152.58K102.49%47.79K64.37%-195.43K51.34%-172.41K-28.93%-495.45K244.72%911.07K
End cash Position -30.86%12.06K-80.85%21.82K-94.71%24.44K-97.25%17.44K-89.92%113.94K21.85%266.52K21.85%266.52K-39.79%461.95K-43.44%634.36K-24.97%1.13M
Free cash from 89.88%-9.76K73.05%-46.27K104.06%7K80.52%-96.5K69.98%-171.68K25.82%-1.44M62.77%-203.83K54.67%-172.41K-27.42%-495.45K9.15%-571.93K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data